Sun W, Tao Y, Yu D, Zhao T, Wu L, Yu W, Han W
Microdosing GLP-1 GIP B12 for longevity A separate and distinct use case has emerged for tirzepatide and GLP-1 class agents: microdosing for metabolic health, anti-inflammatory effects, and longevity, independent of weight loss goals
PE-22-28 inhibits TREK-1 channels with an IC50 of 0.12 nM, compared to 40-60 nM for its parent compound spadin
What makes this category especially interesting is that skin research touches multiple areas at once: structure, resilience, adaptation, and the continuous process of renewal that occurs every day
Patients exploring body composition support may also benefit from Weight Loss guidance
Zhang L, Tian J, Ma L, Duan S